|
Market Closed -
Canadian Securities Exchange
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | - |
| Market Cap | 544K 381K 339K 316K 288K 36.67M 549K 3.83M 1.48M 18.74M 1.43M 1.4M 60.16M | P/E 2022 |
-2.73x | P/E 2023 | -1.64x |
|---|---|---|---|---|---|
| Enterprise Value | 780K 547K 486K 454K 413K 52.59M 787K 5.49M 2.13M 26.88M 2.05M 2.01M 86.28M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
45.03% | Yield 2022 * |
-
| Yield 2023 | - |
| 3 years | 0 |  | 0.08 |
| 5 years | 0 | | 0.08 |
| 10 years | 0 | | 0.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Pinkman
CEO | Chief Executive Officer | 69 | 2019-04-29 |
Alisdair Leeson
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Pinkman
BRD | Director/Board Member | 69 | 2018-01-08 |
Alisdair Leeson
BRD | Director/Board Member | - | 2021-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/23/23 | Estate Of Johannes J Kingma
| Sell | Company | 1,500,000 | 4.1383% | |
| 1/12/22 | Estate Of Johannes J Kingma
| Other | Company | 0 | 0% | - |
| 2/1/21 | Other | Chief Financial Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 381K | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.68% | -3.05% | +26.07% | +58.90% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | -198K -139K -124K -115K -105K -13.37M -200K -1.4M -541K -6.84M -522K -511K -21.94M | -221K -155K -138K -129K -117K -14.92M -223K -1.56M -603K -7.62M -583K -570K -24.47M |
| Net Debt | 213K 149K 133K 124K 113K 14.34M 215K 1.5M 580K 7.33M 560K 548K 23.52M | 236K 166K 147K 137K 125K 15.92M 238K 1.66M 644K 8.14M 622K 608K 26.12M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASIA Stock
Select your edition
All financial news and data tailored to specific country editions
